A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study)

D Price; S Musgrave; E Wilson; E Sims; L Shepstone; A Blyth; J Murdoch; M Mugford; E Juniper; J Ayres; S Wolfe; D Freeman; A Lipp; R Gilbert; I Harvey

doi:10.3310/hta15210

A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study)

D Price, S Musgrave, E Wilson, E Sims, L Shepstone, A Blyth, J Murdoch, M Mugford, E Juniper, J Ayres, S Wolfe, D Freeman, A Lipp, R Gilbert, I Harvey

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)

Original language	English
Pages (from-to)	1-132
Number of pages	132
Journal	Health Technology Assessment
Volume	15
Issue number	21
DOIs	https://doi.org/10.3310/hta15210
Publication status	Published - May 2011

Access to Document

10.3310/hta15210

Cite this

Price, D., Musgrave, S., Wilson, E., Sims, E., Shepstone, L., Blyth, A., Murdoch, J., Mugford, M., Juniper, E., Ayres, J., Wolfe, S., Freeman, D., Lipp, A., Gilbert, R., & Harvey, I. (2011). A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study). Health Technology Assessment, 15(21), 1-132. https://doi.org/10.3310/hta15210

A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study). / Price, D; Musgrave, S; Wilson, E et al.

In: Health Technology Assessment, Vol. 15, No. 21, 05.2011, p. 1-132.

Research output: Contribution to journal › Article › peer-review

Price, D, Musgrave, S, Wilson, E, Sims, E, Shepstone, L, Blyth, A, Murdoch, J, Mugford, M, Juniper, E, Ayres, J, Wolfe, S, Freeman, D, Lipp, A, Gilbert, R & Harvey, I 2011, 'A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study)', Health Technology Assessment, vol. 15, no. 21, pp. 1-132. https://doi.org/10.3310/hta15210

@article{7ef162bf1a8f4e6db0ca1b12c5d4e848,

title = "A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study)",

author = "D Price and S Musgrave and E Wilson and E Sims and L Shepstone and A Blyth and J Murdoch and M Mugford and E Juniper and J Ayres and S Wolfe and D Freeman and A Lipp and R Gilbert and I Harvey",

year = "2011",

month = may,

doi = "10.3310/hta15210",

language = "English",

volume = "15",

pages = "1--132",

journal = "Health Technology Assessment",

issn = "1366-5278",

publisher = "National Co-ordinating Centre for HTA",

number = "21",

}

TY - JOUR

T1 - A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study)

AU - Price, D

AU - Musgrave, S

AU - Wilson, E

AU - Sims, E

AU - Shepstone, L

AU - Blyth, A

AU - Murdoch, J

AU - Mugford, M

AU - Juniper, E

AU - Ayres, J

AU - Wolfe, S

AU - Freeman, D

AU - Lipp, A

AU - Gilbert, R

AU - Harvey, I

PY - 2011/5

Y1 - 2011/5

U2 - 10.3310/hta15210

DO - 10.3310/hta15210

M3 - Article

VL - 15

SP - 1

EP - 132

JO - Health Technology Assessment

JF - Health Technology Assessment

SN - 1366-5278

IS - 21

ER -